Skip to content

Korro Bio, Inc.

KRRO

CIK 0001703647

← back to feed
Revenue (TTM)
$0
−100.0% YoY Q1 May 2026
Net Income (TTM)
−$86.84M
−40.3% YoY Q1 May 2026
EPS Diluted (TTM)
−$8.84
−33.2% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$89.37M
Q1 May 2026
Cash
$61.7M
Q1 May 2026
Total Debt
$180K
Q1 May 2026
Shares Outstanding
14.42M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings